Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The ADME (Absorption, Distribution, Metabolism, and Excretion) Toxicology Testing market is undergoing extensive alterations driven by advancements in pharmaceutical studies, extended regulatory scrutiny, and a developing emphasis on drug protection. There is a first-rate shift toward in vitro checking out models in ADME Toxicology studies. Advanced cellular-based assays and three-D tissue cultures are more and more being applied to evaluate drug metabolism, toxicity, and efficacy. In vitro testing offers an extra powerful and ethical alternative to standard in vivo research, contributing to streamlined drug development methods. Microphysiological structures, additionally known as the organ-on-a-chip era, are gaining prominence in ADME Toxicology. These systems reflect the physiological situations of particular organs, taking into account more accurate and predictive assessments of drug interactions, metabolism, and toxicity. MPS contributes to the discount of animal testing and complements the relevance of preclinical studies.
Regulatory businesses are setting a heightened emphasis on comprehensive safety exams in drug development. ADME Toxicology checking out is an important part of safety evaluation, ensuring that capability risks related to a drug candidate's absorption, distribution, metabolism, and excretion are thoroughly understood earlier than advancing to scientific trials. Collaboration amongst enterprise stakeholders, regulatory bodies, and study institutions is increasing for the standardization and validation of ADME Toxicology checking out techniques. Standardized protocols decorate the reproducibility and reliability of looking at results, selling self-belief in the use of ADME data for selection-making in drug development. The outsourcing of ADME Toxicology trying out offerings is developing. Pharmaceutical agencies are increasingly leveraging the understanding of contract research organizations (CROs) to conduct ADME research efficaciously and successfully. This trend allows agencies to get the right of entry to specialized abilities and resources while preserving flexibility in their drug improvement pipelines.
ADME is trying out locating programs past prescription drugs, extending into environmental toxicology. Researchers use ADME principles to evaluate the destiny and consequences of environmental contaminants, pesticides, and commercial chemical substances. This broader software of ADME testing contributes to environmental risk tests and regulatory compliance. Artificial intelligence and system mastering are being employed to research complex ADME facts sets. These technologies assist in predicting drug metabolism, identifying capacity toxicities, and optimizing drug candidates. AI-pushed strategies enhance the efficiency of information interpretation and contribute to greater informed selection-making in drug improvement.
ADME Toxicology Testing Market Highlights:
Global ADME Toxicology Testing Market Overview
The ADME Toxicology Testing Market is projected to reach USD 3.02 Billion by 2032 at 12.1% CAGR during the forecast period 2023-2032. The ADME Toxicology Screening System is an integrated workstation that describes the properties of pharmacological molecules in terms of absorption, distribution, metabolism, and excretion. The system is equipped with sample testing software that is highly integrated. It also performs precise toxicity tests for drug research and biopharmaceutical manufacturing.
In September 2023, Charles River Laboratories announced a multi-program collaboration agreement with Related Sciences, including high-throughput screening, medicinal chemistry, ADME, biology, pharmacology and ultimately, safety testing and IND submission.
In June 2023, BioIVT hosted an advanced in vitro ADME strategies symposium in Copenhagen.
Thermo Fisher Scientific, a global leader in scientific research and services, introduced a high-throughput in vitro ADME toxicology testing platform (in September 2022). This platform enabled faster and more efficient screening of drug candidates. It helped researchers identify potential toxic effects earlier in the drug development process.
In May 2022, An Asia Pacific launch of Charles River Laboratories’ ADME toxicology testing services happened. The main objective was meeting the demand for drug safety assessment that is fast rising in this area and providing support to pharmaceutical industries as they develop their drugs.
The expansion is part of the recent increase by Eurofins Discovery into its ADME toxicology testing capabilities reported at the beginning of January 2022. For instance, new in vitro models have been incorporated by the company for more accurate and efficient toxicology evaluation.
While excluding Sweden’s market, Thermo Fisher ScientificTM will be able to launch ASTar
In September 2022 exclusively throughout all geographies except one. The partnership is also exclusive to rapid AST testing between both companies. They will work closely together, creating an inclusive AST portfolio for our clients.
In January 2020, Thermofisher Scientific introduced its next-generation compressor-free plate sealer that requires minimal operator maintenance but still provides unmatched levels of customization flexibility during operation as well as significant workflow improvements. For biotech, pharma or academic research laboratory users alike who now have access to technology that streamlines plate sealing while boosting throughput on both standalone projects or integrated robotic systems.
ADME Toxicology Testing Market Trends
The expanding use of ADME toxicology testing by pharmaceutical and biotechnology companies, as well as growing concerns over the use of animals in clinical trials, have aided the expansion of the toxicology testing industry. The region of Asia-Pacific was predicted to be the fastest-growing region for ADME toxicity testing globally. Increased efforts for the development of new diagnostic equipment and the adoption of modern technologies to improve the standard of diagnostic tests. The market is primarily driven by increased medication research and development and rising demand for various disease treatments. Pharmaceutical businesses have benefited from increasing technology breakthroughs and early identification of toxicology in R&D by reducing drug discovery time, expense, and test complications. Furthermore, rising healthcare awareness and increased government and private sector investments in the healthcare sector are expected to drive market expansion. However, high test prices and strict government norms and regulations related to ADME toxicity testing are key roadblocks to industry expansion. During the forecast period, ongoing R&D in the field of ADME toxicity testing is expected to open up new opportunities.
ADME Toxicology Testing Market Segment Insights
The ADME Toxicology Testing Market is segmented on the basis of method, technology, application, and end-user.
ADME Toxicology Testing Method Insights
The Market, by method is categorised into cellular assay, biochemical assay, in silica, and ex-vivo.
ADME Toxicology Testing Technology Insights
The technology segment is categorised into cell culture, high throughput, molecular imaging, and OMICS technology.
ADME Toxicology Testing Application Insights
On the basis of application, the ADME Toxicology Testing Market is segmented into systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and others.
ADME Toxicology Testing End User Insights
On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centres, pathological labs, and others.
ADME Toxicology Testing Regional Insights
On the basis of region, the global ADME Toxicology Testing Market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
It is projected that the Americas dominated the global ADME toxicology testing market owing to the growth in the North America region which is largely attributed to the factors such as increase in research funding, growing awareness on the benefits of ADME toxicology testing for commercial industries, and high adoption of toxicology testing in research. These factors have cumulatively influenced the growth of the market in this regionEurope stood second largest in the ADME toxicology testing market owing to high acceptance of toxicology testing in research. Additionally, development in research expenditure was also responsible for the development of market. Moreover, in January 2014, Cyprotex PLC, a UK based company signed an acquisition agreement with CeeTox, Inc. for its business. The company intended to expand its portfolio for in-vitro toxicity assays and screening services to the Cosmetics and Personal Care Industry.
Asia-Pacific was projected to be the fastest growing region for the global ADME toxicology testing market in 2017. The factors attributed to the due to increased efforts for development of new diagnostic devices and adoption of newer technologies to improve the standard of diagnostics assays being supplied. China and Japan are key countries contributing to market growth.The Middle East and Africa holds the least share in the global ADME toxicology testing market due to the presence of poor health expenditure and economically diverse countries. However, the market is expected to witness growth due to increasing toxicology care programs in the Middle East.
ADME Toxicology Testing Market Segmentation
ADME toxicology testing Method Outlook
- Cellular Assay
- Biochemical Assay
- In Silica
- Ex-vivo
ADME Toxicology Testing Technology Outlook
- Cell Culture
- High Throughput
- Molecular Imaging
- OMICS Technology
ADME toxicology Testing Application Outlook
- Systemic Toxicity
- Renal Toxicity
- Hepatotoxicity
- Neurotoxicity
- Others
ADME Toxicology Testing End-Users Outlook
- Hospitals and clinics
- Diagnostic centers
- Pathological Labs
- Others
ADME Toxicology Testing Region Outlook
- Americas
- Europe
- Asia-Pacific
- Middle East & Africa
Global ADME toxicology testing Global Market, by Key Players:
- Promega Corporation
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Beckman Coulter, Inc.
- Cellartis AB
- Cyprotex PLC.
- Life Technologies Corporation
- Optivia Biotechnology, Inc.
- Accelrys, Inc.
- Molecular Discovery Ltd.
- Cyprotex PLC
- Bio-Rad Laboratories, Inc.
- MultiCASE, Inc.
Recent Development
Machine learning operations platform Chief will be launched in July 2021. The first no-code, pay-as-you-go artificial intelligence (AI) platform for drug development has been established by AI in collaboration with the Medicines Discovery Catapult increasing the stake of the ADME Toxicology Testing Market. Mydecine Innovations Group, an emerging biopharma and life sciences company dedicated to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced the launch of its in-silico drug discovery program in collaboration with University of Alberta researchers in June 2021.
Intended Audience:
-
- Pharmaceutical companies
- Biotechnological institutes
- Diagnostics Laboratories
- Pathological Institutes
- Government and private laboratories
- Research and Development (R&D) companies
- Medical research laboratories
- Market research and consulting service providers
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
